Risk Analysis of Eculizumab-Related Meningococcal Disease in Japan Using the Japanese Adverse Drug Event Report Database

Overview of attention for article published in Drug, Healthcare and Patient Safety, November 2020

Altmetric Badge

Mentioned by

twitter: 1 X user

Citations

dimensions_citation: 17 Dimensions

Readers on

mendeley: 25 Mendeley

Summary X Dimensions citations

So far, Dimensions has found 17 publications that cite this research output.

17

The most recent citing publications are shown below. View all 17 publications that cite this research output on Dimensions.

Real-world safety profile of eculizumab: an analysis of FDA adverse event reporting system and systematic review of case reports

Article in Expert Opinion on Drug Safety (August 2024)

The efficacy and safety of eculizumab in patients and the role of C5 polymorphisms

Article in Drug Discovery Today (August 2024)

Thrombotische Mikroangiopathie

Article in TumorDiagnostik & Therapie (March 2024)